Literature DB >> 21528230

Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC SPES.

H Halicka1, B Ardelt, G Juan, A Mittelman, S Chen, F Traganos, Z Darzynkiewicz.   

Abstract

A herbal preparation denoted PC SPES(R) is available in 'natural food' or 'health food' stores in the United States. This mixture (patent pending, US Serial number 08/697,920) consists of extracts from 8 different herbs, 7 originating from China and one from America, and is sold as a dietary supplement. Although several components of this herbal mixture were reported to have antiproliferative and/or antitumor activity little is known about the possible in vitro cytostatic or cytotoxic properties of the formulation. Composition of PC SPES is standardized by HPLC; the ethanol extract is characterized by the presence of 6 distinct components, reproducible from batch to batch. This extract suppressed cell proliferation and reduced the clonogenicity of a variety of human tumor cell lines, including PC-3 and LNCaP prostate carcinomas, MCF-7 and T47-D breast carcinomas, SK-N-MC neuroepithelioma, Cole 38 melanoma, U937 histiomonocytic lymphoma, as well as HL-60 and MOLT-4 leukemias. The sensitivity to PC SPES was different for particular cell lines, with MCF-7 cells being the most sensitive (IC50 = 20 nl/ml) and Cole 38 the most resistant (IC50 = 430 nl/ml) in clonogenicity assays. The predominant cell cycle effect induced by PC SPES was the prolongation of G(1) phase. Apoptosis was observed after exposure of tumor cells to PC SPES for 48 h and longer. PC SPES also downregulated expression of bcl-2, the gene protecting cells against apoptosis (studied in U937 cells) and sensitized these cells to gamma-irradiation. The cell cycle progression of mitogen stimulated human lymphocytes was not affected at PC SPES concentrations which induced cytotoxic and cytostatic effects in tumor cells. The data indicate that PC SPES is cytostatic and cytotoxic for different tumor cell lines and modulates the cell's propensity to undergo apoptosis.

Entities:  

Year:  1997        PMID: 21528230     DOI: 10.3892/ijo.11.3.437

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines.

Authors:  S Chen; Q Ruan; E Bedner; A Deptala; X Wang; T C Hsieh; F Traganos; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  2001-10       Impact factor: 6.831

Review 2.  Complementary and alternative medicines in prostate cancer: from bench to bedside?

Authors:  Samuel J Klempner; Glenn Bubley
Journal:  Oncologist       Date:  2012-05-22

3.  Analyzing Cytotoxic and Apoptogenic Properties of Scutellaria litwinowii Root Extract on Cancer Cell Lines.

Authors:  Zahra Tayarani-Najaran; Seyed Ahmad Emami; Javad Asili; Alireza Mirzaei; Seyed Hadi Mousavi
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

Review 4.  Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds.

Authors:  Xueni Wang; Gang Fang; Yuzhou Pang
Journal:  Nutrients       Date:  2018-02-28       Impact factor: 5.717

Review 5.  PC-SPES for treatment of prostate cancer: herbal medicine.

Authors:  Ian Yip; Michelle Cudiamat; David Chim
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

6.  Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells.

Authors:  Kaikai Wu; Kun Na; Dian Chen; Yujie Wang; Haitao Pan; Xingya Wang
Journal:  Int J Oncol       Date:  2018-09-28       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.